Proceedings of the Fourth International Meeting of OIE and WHO Experts on Control of Equine Influenza : surveillance and vaccine efficacy : the American perspective : 3rd-5th August 1999, Miami, Florida, USA /
| Corporate Authors: | , |
|---|---|
| Other Authors: | , , |
| Format: | Conference Proceeding Book |
| Language: | English |
| Published: |
Newmarket, U.K. :
R & W Publications,
2003.
|
| Series: | Havemeyer Foundation monograph series ;
no. 7. |
| Subjects: |
Table of Contents:
- Overview of equine influenza from the American perspective
- International collating centre report
- Regional reports of outbreaks diagnosed and domestic vaccination policies
- Discussion
- Genetic analysis based on nucleotide sequence of the HA and other genes
- Antigenic analysis based on serological tests using ferret and horse sera and monoclonal antibodies
- Discussion
- Report on activities of the Equine Influenza Expert Surveillance Panel
- Review of criteria used for vaccine strain selection
- Comparison of sera from different species for antigenic analysis
- The use of post vaccination field sera to differentiate between virus strains
- Significance of antigenic variation for vaccine efficacy - studies in horses
- Studies in hamsters
- Currently available vaccines
- Vaccine characteristics and performance - comparative serological studies
- Effect of maternal antibodies on the response to vaccination
- Duration of immunity
- Responses to vaccination in young Thoroughbreds
- Protection against experimental infection - correlates of immunity
- Protection against field infection
- Novel approaches to vaccination
- Discussion
- OIE standards
- European perspective
- American perspective
- Provision of standards
- Discussion
- OIE Code and Standard
- Regional regulations and transport issues
- Inadequate monitoring of field influenza as a factor contributing to the lack of control of influenza
- Discussion
- Role of vaccine manufacturers
- International movement and disease control
- Extending the surveillance network
- Main conclusions and recomendations of the meeting
- Recommendations for virus vaccine strains